Alternative Asset Management, Corporate Services | Madrid
Our venture capital (VC) team invests in the future of European businesses. Formed in 2019, the VC team invests both directly in innovative European companies and in top performing fund managers. Our ambition is to be the best-in-class trusted partner in venture and growth capital and our mission encompasses three objectives: to provide investors with products of the highest standard, to be an engaged and committed ally to our investments and to support our team members to be the best professionals.
Alantra entered venture capital via strategic partnership with Asabys Partners, an early stage VC fund investing in human healthcare across Europe. Asabys, in which Alantra holds a 35% stake, invests in early stage therapeutic companies in human health life sciences across the board in biotech, medtech and healthcare innovation (digital therapeutics). The team is made up of a group of veterans in health-related investments with a solid track record. In addition, they bring their capabilities in building and selling businesses to major corporations in the healthcare industry. If you want to learn more about Asabys, click here.